Clinical Trials Directory

Trials / Unknown

UnknownNCT02876133

Narrow Band Imaging Versus White Light for Colonoscopy Serrate Lesions Detection

Improving Colorectal Cancer Screening: Using Narrow Band Imaging for Colonic Sessile Serrated Lesions

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
987 (estimated)
Sponsor
Hospital Beatriz Ângelo · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Accepted

Summary

Colorectal cancer (CRC) is a leading cause of cancer death and its' incidence is rising in most European countries. Colonoscopy has been shown to reduce CRC incidence, however its effectiveness depends on the sensitivity to detect pre-malignant lesions. Our aim is to evaluate narrow band imaging (NBI) during colonoscopy and serum miRNAs as novel tools for the early detection of colonic sessile serrated lesions (SSL). The investigators will perform a multicenter-randomized-controlled-trial to study the role of NBI in SSL detection.

Conditions

Interventions

TypeNameDescription
DEVICEnarrow band imaging withdrawalcolonoscope withdrawal and mucosal inspection performed under narrow band imaging
DEVICEwhite light withdrawalcolonoscope withdrawal and mucosal inspection performed under white light imaging

Timeline

Start date
2016-11-01
Primary completion
2019-08-01
Completion
2019-08-01
First posted
2016-08-23
Last updated
2018-09-26

Locations

3 sites across 1 country: Portugal

Source: ClinicalTrials.gov record NCT02876133. Inclusion in this directory is not an endorsement.